Publications by authors named "James Finklea"

Claim this Profile
I
Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index.
Andrew Horvit, Katie Kaput, Amber Neece, Jessica Abramowitz, Marconi Abreu, James D Finklea

J Cyst Fibros· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.
Gregory A Ratti, Hannah Smith, Sasan Mirfakhraee, Joan Reisch, Leah Cohen, James D Finklea

J Cyst Fibros· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.
Christina Koenig, Marguerite L Monogue, Ryan K Shields, Colleen M Sakon, Andrew J Fratoni, James D Finklea

Antimicrob Agents Chemother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic epidemiology of at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.
Jane E Gross, James D Finklea, Silvia M Caceres, Katie R Poch, Nabeeh A Hasan

ERJ Open Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.
Angela Wang, MinJae Lee, Ashley Keller, Sarah Jian, Karen Lowe, James D Finklea

J Cyst Fibros· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
Marc D Esquivel, Marguerite L Monogue, Greg S Smith, James D Finklea, James M Sanders

J Glob Antimicrob Resist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Patrick J Nolan, Raksha Jain, Leah Cohen, James D Finklea, Tiffeny T Smith

Diagn Microbiol Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy.
Allison V Lange, Ali Rueschhoff, Stephanie Terauchi, Leah Cohen, Joan Reisch, James D Finklea

J Palliat Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
James D Finklea, Rita Hollaway, Karen Lowe, Francesca Lee, Jade Le

Diagn Microbiol Infect Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-resistant from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.
Stan D Atkin, Shadaan Abid, Michael Foster, Moumita Bose, Ashley Keller, James D Finklea

Infect Drug Resist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung transplantation and gender effects on survival of recipients with cystic fibrosis.
Deepa Raghavan, Ang Gao, Chul Ahn, Vaidehi Kaza, James Finklea

J Heart Lung Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study.
Jenny E Han, Antoine R Trammell, James D Finklea, Timothy N Udoji, Daniel D Dressler

J Grad Med Educ· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies.
James D Finklea, Ruth E Grossmann, Vin Tangpricha

Adv Nutr· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis.
James D Finklea, Gul Khan, Sheree Thomas, Juhee Song, Dennis Myers

Respir Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis